search icon

    Market Snapshot

    blog search icon

    Clearside Biomedical, Inc. Stock Profile, Price, History

    Clearside Biomedical, Inc.

    (NASDAQ:CLSD)

    $1.51

    0.10 (7.09%)

    At Close: 4:00 PM

    $1.54

    0.03 (1.99%)

    After Market: 10:32 PM

    Clearside Biomedical, Inc.

    • 1D
    • 5D
    • 1M
    • 3M
    • 6M
    • 1Y
    • YTD
    • All

    CLSD Stock Price Today

    Clearside Biomedical, Inc. (CLSD) stock rallied over 7.09% intraday to trade at $1.51 a share on NASDAQ. The stock opened with a gain of 8.51% at $1.53 and touched an intraday high of $1.628, rising 7.09% against the last close of $1.41. The Clearside Biomedical, Inc. in stock market went to a low of $1.48 during the session.

    Stock Snapshot

    $1.41

    Prev. Close

    90.95 Million

    Market Cap

    $1.48

    Day Low

    $1.53

    Open

    60.19 Million

    Number of Shares

    $1.628

    Day High

    -

    P/E ratio

    -0.10

    EPS (TTM)

    0.48

    Cash Flow per Share

    0.40

    Free Float in %

    0.17

    Book Value

    409,357

    Volume

    Contact Details

    900 North Point Parkway
    Suite 200
    Alpharetta, GA 30005
    United States

    Website:https://www.clearsidebio.com

    Contact #:678 270 3631

    Company Information

    Employees34

    Beta1.91

    Sales or Revenue$29.49 Million

    5Y Sales Change124.40%

    Fiscal Year EndsDec. 2021

    SectorHealth Care

    IndustryPharmaceuticals

    About Company

    Clearside Biomedical, Inc., a biopharmaceutical company, focuses on the revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space. The company offers XIPERE, a triamcinolone acetonide suprachoroidal injectable suspension for the treatment of uveitis macular edema. It also develops CLS-AX, an axitinib injectable suspension for suprachoroidal injection, which is in Phase 1/2a clinical trial; and CLS-301, an integrin inhibitor suspension for the treatment of diabetic macular edema and macular degeneration. The company has a collaboration with Bausch Health, Arctic Vision, REGENXBIO, Inc., and Aura Biosciences. Clearside Biomedical, Inc. was incorporated in 2011 and is headquartered in Alpharetta, Georgia.

    Frequently Asked Questions

    icon

    What is the current Clearside Biomedical, Inc. (CLSD) stock price?

    Clearside Biomedical, Inc. (NASDAQ: CLSD) stock price is $1.51 in the last trading session. During the trading session, CLSD stock reached the peak price of $1.628 while $1.48 was the lowest point it dropped to. The percentage change in CLSD stock occurred in the recent session was 7.09% while the dollar amount for the price change in CLSD stock was $0.10.

    icon

    CLSD's industry and sector of operation?

    The NASDAQ listed CLSD is part of Pharmaceuticals industry that operates in the broader Health Care sector. Clearside Biomedical, Inc. , a biopharmaceutical company, focuses on the revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space.

    icon

    Who are the executives of CLSD?

    Mr. Leslie B. Zacks
    Gen. Counsel, Chief Compliance Officer & Sec.
    Dr. George M. Lasezkay J.D., Pharm.D., Pharma.D.
    Pres, CEO & Director
    Mr. Charles A. Deignan
    Chief Financial Officer
    Dr. Thomas A. Ciulla M.B.A., M.D.
    Chief Medical Officer & Chief Devel. Officer

    icon

    How CLSD did perform over past 52-week?

    CLSD's closing price is 0.54% higher than its 52-week low of $0.98 where as its distance from 52-week high of $2.85 is -0.47%.

    icon

    How many employees does CLSD have?

    Number of CLSD employees currently stands at 34. CLSD operates from 900 North Point Parkway, Suite 200, Alpharetta, GA 30005, United States.

    icon

    Link for CLSD official website?

    Official Website of CLSD is: https://www.clearsidebio.com

    icon

    How do I contact CLSD?

    CLSD could be contacted at phone #678 270 3631 and can also be accessed through its website. CLSD operates from 900 North Point Parkway, Suite 200, Alpharetta, GA 30005, United States.

    icon

    How many shares of CLSD are traded daily?

    CLSD stock volume for the day was 409,357 shares. The average number of CLSD shares traded daily for last 3 months was 298.07 Thousands.

    icon

    What is the market cap of CLSD currently?

    The market value of CLSD currently stands at $90.95 Million with its latest stock price at $1.51 and 60.19 Million of its shares outstanding.